ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $166,000 | -20.2% | 47,800 | -46.9% | 0.00% | -50.0% |
| Q4 2018 | $208,000 | +477.8% | 90,100 | +663.6% | 0.00% | – |
| Q1 2016 | $36,000 | -98.0% | 11,800 | -97.5% | 0.00% | -100.0% |
| Q4 2015 | $1,810,000 | +132.9% | 470,197 | +520.5% | 0.01% | +42.9% |
| Q2 2014 | $777,000 | -43.2% | 75,781 | -33.5% | 0.01% | -46.2% |
| Q1 2014 | $1,369,000 | -19.3% | 113,977 | -24.0% | 0.01% | +18.2% |
| Q4 2013 | $1,697,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |